ArticleInternational journal of hematology2025
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities.
Junji Ikeda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it